This dataset contains summary data visualizations and clinical data from the targeted sequencing of 10,000 clinical cases using the MSK-IMPACT assay. The clinical data includes mutation count, information about mutated genes, tumor mutational burden calculations, tissue site from which the sample was derived, tumor purity among other relevant data points. The data set also includes copy-number segment...

This dataset contains summary data visualizations and clinical data from a sampling of gallbladder tumors. The clinical data includes deidentified patient and sample IDs, mutation count, the fraction of genome that was altered, patient demographics, sample site, MSK IMPACT gene panel, Center of sequencing, Collaboration Id, Gallbladder Stone , Gene Panel, Metastatic Site, Oncotree Code, Primary Tumor...

From GEO summary: The impact of different carcinogenic exposures on the specific patterns of somatic mutations in human tumors remains unclear. To clarify this issue, we profiled 209 cholangiocarcinomas (CCAs) from Asia and Europe, including 108 cases caused by liver fluke Opisthorchis viverrini (OV)-infection and 101 cases due to non-OV etiologies. Whole-exome (N = 15) and prevalence screening (N...

From GEO Summary: The impact of different carcinogenic exposures on the specific patterns of somatic mutations in human tumors remains unclear. To clarify this issue, we profiled 209 cholangiocarcinomas (CCAs) from Asia and Europe, including 108 cases caused by liver fluke Opisthorchis viverrini (OV)-infection and 101 cases due to non-OV etiologies. Whole-exome (N = 15) and prevalence screening (N...

This dataset contains summary data visualizations and clinical data from a sampling of gallbladder carcinoma tumors. The clinical data includes deidentified patient and sample IDs, mutation count, patient demographics (age and gender) and survival status, presence of ErbB Pathway Mutation, presence of gallbladder stone, presence of jaundice, presence of lymph nodes metastasis, presence of perineural...

Whole Exome Sequencing of 16 non-liver fluke (OV) associated cholangiocarcinomas. Study conducted by Duke NUS Medical School in Singapore containg 471 sequence runs.